Healius Limited (HLS.AX)
Operates medical laboratories across Australia that test patient blood and tissue samples
0.38+0.07%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-50.3%
The outlook
Healius trades near the lower end of its 52-week range, with analyst consensus at "Hold" and mixed momentum against moving averages. The average analyst target sits roughly 32% above the current price, though overall sentiment leans cautious. Coverage is moderate at 10 analysts.
What’s behind the score
Analyst consensusHold — 3.5 avg of 10 analysts
Price trendMixed vs its moving averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +32% vs current price
Analyst price target
~12-month · 10 analysts0.50average target+32.3% vs now
Now 0.38
Low 0.27High 1.30
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$272.3M
52-wk high
1.07
52-wk low
0.30
50-day avg
0.36
200-day avg
0.66
Trailing P/E
—